#14 of pharma imports · Antibiotics
Amoxicillin & salts: imports into India
Tariff line 29411030 · CAS 26787-78-0
Imports 2025-26
1,392 t
+9.3% vs 2024-25
Import bill (CIF, before duty)
₹309 cr
Volume growth, 2020-21 to 2025-26
+6.5% a year
Rising
Net imports 2025-26
-4,157 t
Exports 5,549 t
Import volume by financial year
RisingShow as table
| Year | Imports | Import bill |
|---|---|---|
| 2020-21 | 1,015 t | ₹196 cr |
| 2021-22 | 640 t | ₹147 cr |
| 2022-23 | 1,249 t | ₹371 cr |
| 2023-24 | 1,264 t | ₹389 cr |
| 2024-25 | 1,273 t | ₹363 cr |
| 2025-26 | 1,392 t | ₹309 cr |
Where it comes from (2025-26)
Share of the import bill
- China89.4%
- Netherlands6%
- Austria1.9%
What's changing
- Upstream supply is being built in India: Aurobindo Pharma commissioned a 15,000 t/yr Penicillin-G plant (Lyfius Pharma) and a 3,600 t/yr 6-APA plant (Qule Pharma) in the Kakinada SEZ; both are starting materials for amoxicillin.Indian Pharma Post, 2 Apr 2024
- DGTR opened an anti-dumping investigation into amoxicillin trihydrate from China in late September 2026, on an application by Apitoria Pharma.Open Magazine, 29 Sept 2026
Reported facts with their source. Not a forecast.
Buy or supply amoxicillin & salts in India
Source: Export Import Data Bank, Department of Commerce (DGCI&S data), as published on 10 Nov 2026. The import bill is the total declared value, not a price per kg. How to read these figures.